Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anticancer or carcinogenic? The role of estrogen receptor β in breast cancer progression
Kang Shen, Huiguang Yu, Baohua Xie, et al.
Pharmacology & Therapeutics (2023) Vol. 242, pp. 108350-108350
Closed Access | Times Cited: 24

Showing 24 citing articles:

Molecular hybridization: a powerful tool for multitarget drug discovery
Pedro de Sena Murteira Pinheiro, Lucas Silva Franco, Tadeu L. Montagnoli, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 4, pp. 451-470
Closed Access | Times Cited: 44
PROTACs: A novel strategy for cancer drug discovery and development
Xin Han, Yi Sun
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 25
Chitosan and hyaluronic acid in breast cancer treatment: Anticancer efficacy and nanoparticle and hydrogel development
Yanlin Jiang, Yu Cao, Yiqun Yao, et al.
International Journal of Biological Macromolecules (2025) Vol. 301, pp. 140144-140144
Closed Access | Times Cited: 1
Discovery of a Novel Class of PROTACs as Potent and Selective Estrogen Receptor α Degraders to Overcome Endocrine-Resistant Breast Cancer In Vitro and In Vivo
Baohua Xie, Zhinang Yin, Zhiye Hu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 10, pp. 6631-6651
Closed Access | Times Cited: 17
Discovery of Novel ERα and Aromatase Dual-Targeting PROTAC Degraders to Overcome Endocrine-Resistant Breast Cancer
Lilan Xin, Chao Wang, Yan Cheng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 8913-8931
Closed Access | Times Cited: 8
Small molecule conjugates with selective estrogen receptor β agonism promote anti-aging benefits in metabolism and skin recovery
Tarik Zahr, Vijay K. Boda, Jian Ge, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 2137-2152
Open Access | Times Cited: 5
Role of ERβ in the ovary and ovary related diseases
Xuewei Bao, Di Yan, Jing Yang, et al.
Gene (2024) Vol. 927, pp. 148678-148678
Closed Access | Times Cited: 5
Identification of Novel Dual-Target Estrogen Receptor α Degraders with Tubulin Inhibitory Activity for the Treatment of Endocrine-Resistant Breast Cancer
Xiangping Deng, Xiaofei Deng, Wentao Ning, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 11094-11117
Closed Access | Times Cited: 12
Structure-guided identification of novel dual-targeting estrogen receptor α degraders with aromatase inhibitory activity for the treatment of endocrine-resistant breast cancer
Lilan Xin, Jian Min, Hebing Hu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 253, pp. 115328-115328
Open Access | Times Cited: 11
Discovery of estrogen receptor α targeting caged hypoxia-responsive PROTACs with an inherent bicyclic skeleton for breast cancer treatment
Baohua Xie, Bin Xu, Lilan Xin, et al.
Bioorganic Chemistry (2023) Vol. 137, pp. 106590-106590
Closed Access | Times Cited: 11
A Dopamine‐Modified Hyaluronic Acid‐Based Mucus Carrying Phytoestrogen and Urinary Exosome for Thin Endometrium Repair
Chenchen Li, Xiyang Tan, Dashi Deng, et al.
Advanced Materials (2024)
Open Access | Times Cited: 4
A Comprehensive Review of Small Molecules, Targets, and Pathways in Ulcerative Colitis Treatment
Xiaoxuan Cai, Yi-Han Huang, Yang-Chi-Dung Lin, et al.
European Journal of Medicinal Chemistry (2025) Vol. 291, pp. 117645-117645
Closed Access
Fluorescence theranostic PROTACs for real-time visualization of ERα degradation
Xiaohua Wang, Lilan Xin, Xiaofei Deng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116184-116184
Closed Access | Times Cited: 3
Targeting the crosstalk between estrogen receptors and membrane growth factor receptors in breast cancer treatment: Advances and opportunities
Shunchao Yan, Jiale Ji, Zhijie Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116615-116615
Open Access | Times Cited: 3
A novel photostable near-infrared fluorescent selective estrogen receptor modulator (SERM) for live-cell 3D imaging of breast cancer
Chunmei Yang, Pei He, Qiuyu Meng, et al.
Sensors and Actuators B Chemical (2024) Vol. 407, pp. 135454-135454
Closed Access | Times Cited: 2
Novel oral selective estrogen receptor degraders (SERDs) to target hormone receptor positive breast cancer: elacestrant as the poster-child
Jennifer C Keenan, Arielle J. Medford, Charles Dai, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 6, pp. 397-405
Closed Access | Times Cited: 2
Development of Highly Efficient Estrogen Receptor β-Targeted Near-Infrared Fluorescence Probes Triggered by Endogenous Hydrogen Peroxide for Diagnostic Imaging of Prostate Cancer
Pei He, Xiaofei Deng, Bin Xu, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2309-2309
Open Access | Times Cited: 6
Synthesis and Comprehensive Characterization of PVA/Chitosan/Cu Nanowires Wound Dressing Hydrogel for Effective In Vitro Wound Healing
Mojtaba Jallab, Mina Ghaheri, Bita Javan, et al.
Journal of Industrial and Engineering Chemistry (2024)
Closed Access | Times Cited: 1
Structure-based virtual screening, molecular simulation and free energy calculations of traditional Chinese medicine, ZINC database revealed potent inhibitors of estrogen-receptor α (ERα)
Muhammad Shahab, Maryam Zulfat, Guojun Zheng
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 23, pp. 13261-13274
Closed Access | Times Cited: 2
The endocrine disruptor cadmium modulates the androgen–estrogen receptors ratio and induces inflammatory cytokines in luminal (A) cell models of breast cancer
Viviana M. Bimonte, Giuseppina Catanzaro, Agnese Pò, et al.
Endocrine (2023) Vol. 83, Iss. 3, pp. 798-809
Open Access | Times Cited: 2
Non-vesicular nanocarriers for breast cancer management: current advances, challenges, and future perspective
Nalla Usha Kumari, Ekta Pardhi, Jitender Madan, et al.
International Journal of Polymeric Materials (2024), pp. 1-21
Closed Access
Chemoprevention strategies in hereditary breast and ovarian cancer syndromes
Elena Barbieri, Marta Venturelli, Luciana Mastrodomenico, et al.
Tumori Journal (2024)
Closed Access
The importance of selected biomarkers in the clinical practice of breast cancer patients
Agata Makówka, Beata Kotowicz
Nowotwory Journal of Oncology (2023) Vol. 73, Iss. 5, pp. 277-285
Open Access | Times Cited: 1
Fluorescence Theranostic PROTACs for Real-Time Visualization of ERα Degradation
Xiaohua Wang, Lilan Xin, Xiaofei Deng, et al.
(2023)
Closed Access
Page 1

Scroll to top